Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
260M
-
Number of holders
-
688
-
Total 13F shares, excl. options
-
197M
-
Shares change
-
+1.14M
-
Total reported value, excl. options
-
$3.71B
-
Value change
-
+$65.5M
-
Put/Call ratio
-
0.92
-
Number of buys
-
294
-
Number of sells
-
-309
-
Price
-
$18.80
Significant Holders of Organon & Co. - Common Stock (OGN) as of Q1 2024
795 filings reported holding OGN - Organon & Co. - Common Stock as of Q1 2024.
Organon & Co. - Common Stock (OGN) has 688 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 197M shares
of 260M outstanding shares and own 75.82% of the company stock.
Largest 10 shareholders include BlackRock Inc. (33.5M shares), VANGUARD GROUP INC (30.8M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (10.2M shares), STATE STREET CORP (9.3M shares), CITADEL ADVISORS LLC (6.18M shares), Slate Path Capital LP (5.15M shares), MORGAN STANLEY (5.04M shares), Sound Shore Management Inc /CT/ (5.02M shares), LSV ASSET MANAGEMENT (4.49M shares), and Bank of New York Mellon Corp (4M shares).
This table shows the top 688 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.